UFF
ABBV icon

USA Financial Formulas’s AbbVie ABBV Stock Holding History

USA Financial Formulas’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.8K Buy
158
+155
+5,167% +$33.3K 0.01% 307
2026
Q1 		$652 Hold
3
– – ﹤0.01% 365
2025
Q4 		$685 Buy
+3
New +$683 ﹤0.01% 339
2022
Q3 		$3K Sell
20
-5,219
-100% -$749K ﹤0.01% 139
2022
Q2 		$802K Sell
5,239
-1,250
-19% -$191K 1% 40
2022
Q1 		$1.05M Buy
6,489
+6,463
+24,858% +$939K 1.13% 23
2021
Q4 		$4K Sell
26
-560
-96% -$66.2K ﹤0.01% 224
2021
Q3 		$63K Buy
586
+102
+21% +$11.7K 0.06% 178
2021
Q2 		$55K Buy
484
+459
+1,836% +$51.7K 0.05% 208
2021
Q1 		$3K Sell
25
-754
-97% -$80.7K ﹤0.01% 244
2020
Q4 		$83K Buy
+779
New +$74.9K 0.07% 151
2018
Q4 		– Sell
-2,585
Closed -$240K – 316
2018
Q3 		$240K Sell
2,585
-31,475
-92% -$2.98M 0.06% 243
2018
Q2 		$3.22M Sell
34,060
-258
-0.8% -$25.2K 0.78% 55
2018
Q1 		$3.25M Sell
34,318
-4,945
-13% -$543K 0.78% 55
2017
Q4 		$3.8M Buy
+39,263
New +$3.7M 0.9% 44
2017
Q3 		– Sell
-5,887
Closed -$427K – 241
2017
Q2 		$427K Buy
5,887
+1,368
+30% +$92K 0.1% 186
2017
Q1 		$294K Buy
4,519
+363
+9% +$22.8K 0.07% 198
2016
Q4 		$260K Buy
+4,156
New +$254K 0.06% 210
2016
Q3 		– Sell
-3,233
Closed -$200K – 219
2016
Q2 		$200K Buy
+3,233
New +$197K 0.05% 203

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

USA Financial Formulas's ABBV Position: Q2 2026 in Review

USA Financial Formulas increased its AbbVie (ABBV) stake by 5,167% in Q2 2026, buying an estimated $33.3K and bringing the position to 158 shares worth $39.8K. The position accounts for 0.01% of the portfolio, ranked #307.

USA Financial Formulas first reported a position in ABBV in Q2 2016 and has held it in 19 quarters since. The position peaked at $3.8M in Q4 2017. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • USA Financial Formulas held 158 shares of AbbVie worth $39.8K as of Q2 2026.
  • USA Financial Formulas bought 155 AbbVie shares in Q2 2026, an estimated $33.3K.
  • AbbVie made up 0.01% of USA Financial Formulas's portfolio in Q2 2026, its #307 holding.
  • USA Financial Formulas first reported a position in AbbVie in Q2 2016 and has held it in 19 quarters since.
  • USA Financial Formulas's AbbVie position peaked at $3.8M in Q4 2017.
  • 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on USA Financial Formulas's 13F filing for Q2 2026, filed 4 Aug 2026.